Quick Answer
Kalaris Therapeutics, Inc. reported Revenue (ASC 606) of $165.0 thousand for fiscal year 2019.
Kalaris Therapeutics, Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2019 | $165.0K | — |
- The most recent figure is from Kalaris Therapeutics, Inc.’s fiscal year 2020 report (Form 10-K), filed with the SEC on February 12, 2021.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: